CellPly's Grant

CellPly raised a round of funding on October 01, 2016. Investors include Horizon 2020.

Cellply is a biotechnology company committed to the development of solutions for personalized cancer therapy based on diagnostic platforms that define cell response to drug treatments. Its micro-techn…

Articles about CellPly's Grant: